Market cap
₹144 Cr
Revenue (TTM)
₹112 Cr
P/E Ratio
9.6
P/B Ratio
1.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 5.86 | -30.24 | 7.61 | 20.46 | -- |
| EBIT | -41.44 | 792.50 | 54.82 | 36.72 | -- |
| Net Profit | -28.76 | 48.04 | 46.47 | 48.95 | -- |
| EPS | -28.75 | 48.05 | 46.47 | 29.58 | -- |
| Book Value | -- | -- | 107.87 | 75.32 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| 14.92 | -- | 15.58 | 14.76 | 18.16 |
| Net Margin
| 10.96 | -- | 13.13 | 12.54 | 12.19 |
| Return on equity
| 36.97 | -- | 16.08 | 24.56 | 46.13 |
| Return on Capital
| 43.64 | -- | -- | 26.87 | 57.51 |
| Return on Assets
| 15.34 | -- | 27.02 | 14.89 | 18.78 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.37 | 0.18 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
26.87
|
57.51
|
46.54
|
55.00
|
|
Peer Median
|
--
|
14.72
|
18.85
|
11.60
|
--
|
ROE
16.08
Higher than Peers by 5.22
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
16.08
|
24.56
|
46.13
|
40.21
|
51.69
|
|
Peer Median
|
10.86
|
11.67
|
14.92
|
11.46
|
--
|
ROA
27.02
Higher than Peers by 20.28
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
27.02
|
14.89
|
18.78
|
12.34
|
15.43
|
|
Peer Median
|
6.74
|
7.86
|
9.06
|
6.44
|
--
|
EBIT Margin
15.58
Higher than Peers by 2.89
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
15.58
|
14.76
|
18.16
|
11.83
|
10.10
|
|
Peer Median
|
12.69
|
15.03
|
14.71
|
12.37
|
--
|
Net Margin
13.13
Higher than Peers by 4.27
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
13.13
|
12.54
|
12.19
|
8.15
|
6.89
|
|
Peer Median
|
8.86
|
9.33
|
8.49
|
10.02
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
0.00
|
13.66
|
12.91
|
9.08
|
7.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
7.61
Lower than Peers by 0.53
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
7.61
|
25.92
|
33.94
|
3.63
|
95.91
|
|
Peer Median
|
8.14
|
10.27
|
11.85
|
9.08
|
--
|
EBIT Growth
54.82
Higher than Peers by 37.57
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
54.82
|
2.33
|
105.57
|
21.47
|
486.10
|
|
Peer Median
|
17.24
|
24.15
|
28.00
|
-3.12
|
--
|
Net Profit Growth
46.47
Higher than Peers by 29.62
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
46.47
|
34.40
|
100.08
|
22.90
|
526.72
|
|
Peer Median
|
16.85
|
30.29
|
36.51
|
-0.85
|
--
|
EPS Growth
46.47
Higher than Peers by 35.88
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
46.47
|
-2.09
|
80.81
|
22.90
|
526.68
|
|
Peer Median
|
10.60
|
24.50
|
--
|
-6.82
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
185.35
|
89.86
|
51.09
|
69.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
Lower than Peers by 0.03
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
0.01
|
0.37
|
0.18
|
0.27
|
0.31
|
|
Peer Median
|
0.04
|
0.23
|
0.20
|
0.15
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
0.35
|
0.13
|
0.15
|
0.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.31
Higher than Peers by 5.59
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
7.31
|
2.88
|
1.67
|
1.16
|
1.17
|
|
Peer Median
|
1.72
|
1.79
|
1.96
|
2.08
|
--
|
Quick Ratio
4.23
Higher than Peers by 3.05
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
4.23
|
2.30
|
1.13
|
0.78
|
1.12
|
|
Peer Median
|
1.17
|
1.47
|
1.44
|
1.58
|
--
|
Interest Coverage
10.77
Higher than Peers by 2.90
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
10.77
|
21.63
|
19.54
|
13.97
|
20.45
|
|
Peer Median
|
7.86
|
9.42
|
8.58
|
15.41
|
--
|
Operating Efficiency
Debtors to sales
32.39
Higher than Peers by 6.60
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
32.39
|
28.89
|
29.61
|
32.35
|
37.09
|
|
Peer Median
|
25.79
|
25.82
|
26.12
|
22.96
|
--
|
Asset Turnover
2.01
Higher than Peers by 1.35
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
2.01
|
1.14
|
1.54
|
1.51
|
2.24
|
|
Peer Median
|
0.67
|
0.75
|
0.77
|
0.65
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
95.62
|
98.10
|
124.35
|
95.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
65.81
|
60.30
|
36.25
|
5.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
60.76
|
157.99
|
181.85
|
102.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
100.68
|
0.42
|
-21.25
|
-0.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
9.60
Lower than Peers by 30.30
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
9.60
|
12.38
|
--
|
--
|
--
|
|
Peer Median
|
39.90
|
39.70
|
33.48
|
37.74
|
--
|
Price / Book Value
1.49
Lower than Peers by 2.74
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
1.49
|
2.05
|
--
|
--
|
--
|
|
Peer Median
|
4.23
|
3.72
|
4.21
|
3.22
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
0.16
|
0.21
|
0.57
|
--
|
EV/EBITDA
7.31
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
7.31
|
9.79
|
1.07
|
0.63
|
0.40
|
|
Peer Median
|
--
|
30.23
|
29.90
|
28.81
|
--
|
Market Cap
144
Lower than Peers by 7,468
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Quest Laboratories
|
144
|
168
|
--
|
--
|
--
|
|
Peer Median
|
7,613
|
4,851
|
2,099
|
15,272
|
--
|